title: Differential protein expression profiles in salicylate ototoxicity of the mouse cochlea.
abstract: The purpose of this study was to investigate protein expression profiles of salicylate ototoxicity using proteomic analysis, and to identify whether salicylates induce apoptosis in organotypic culture of mouse cochlear cells. The adult mice were injected intraperitoneally with 400mg/kg of sodium salicylate. Approximately 30dB threshold shift was observed 3h after the injection, and the hearing threshold returned to normal range within 3 days. Proteomic analysis of mouse cochlea was performed 3h after salicylate injection, because this was the time to show maximal ototoxic effect in salicylate intoxication. Expression pattern of proteomic analysis at 3h was compared with those of normal cochlea and cochlea 3 days after salicylate injection. Sixteen proteins were transiently up-regulated threefolds or more at 3h after the injection compared with normal cochlea, and three proteins were down-regulated at 3h. Similar protein expression profiles were also observed between normal and 3 days group. These up-regulated and down-regulated proteins at 3h were analyzed by MALDI-TOF MS. The mRNA expressions of nine selected genes from 16 up-regulated protein profiles were also investigated by RT-PCR, and their expression levels at 3h were found to be higher than those of normal cochlea. We also confirmed the ototoxicity of salicylate in organotypic culture of cochlear cells using MTT assay, Hoechst staining and DNA laddering assay in vitro, and found that salicylate decreased the viability of cells in a time and dose-dependent manner, and that induced apoptosis in organotypic culture of cochlear cells. This study demonstrated that some proteins can be related to salicylate ototoxicity, and provides basic information about candidate proteins which are related to pathologic changes in salicylate-induced ototoxicity.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Republic of Korea. ranccoon@naver.com
authors.forename: Hak Hyun
authors.initials: HH
authors.lastname: Jung
authors.forename: Hyung Jin
authors.initials: HJ
authors.lastname: Kim
authors.forename: Gi Jung
authors.initials: GJ
authors.lastname: Im
authors.forename: Jiwon
authors.initials: J
authors.lastname: Chang
authors.forename: June
authors.initials: J
authors.lastname: Choi
authors.forename: Sung Won
authors.initials: SW
authors.lastname: Chae
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001483:Base Sequence; D002478:Cells, Cultured; D003051:Cochlea / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D053938:DNA Fragmentation / Q000187:drug effects; D017931:DNA Primers / Q000235:genetics; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D040081:Protein Array Analysis; D011506:Proteins / Q000235:genetics* / Q000378:metabolism*; D040901:Proteomics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012980:Sodium Salicylate / Q000633:toxicity*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D017931:DNA Primers; D011506:Proteins; D012333:RNA, Messenger; D012980:Sodium Salicylate